Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Literature
1.
Starling, et al. Mismatch repair screening of gastrointestinal cancers: the impact on lynch syndrome detection and immunotherapy. J Gastrointest Cancer. 2022;26;1–8.
2.
Seppälä TT, Latchford A, Negoi I, Sampaio Soares A, Jimenez-Rodriguez R, Sánchez-Guillén L, et al. European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg. 2021;108:484–98.
3.
Olson K, Debelenko L, Stringel G, Da Dong X. Early onset colon cancer affected by Lynch syndrome. J Pediatr Surg Case Rep. 2018;36:13–5.CrossRef
4.
Weiss JM, Gupta S, Burke CA, Axell L, et al. NCCN Guidelines® insights: genetic/familial high-risk assessment: colorectal, Version 1.2021. J Natl Compr Canc Netw. 2021;19:1122–1132. 
Metadata
Title
Would it be Reasonable to Perform a Prophylactic Appendicectomy in Patients Diagnosed with Lynch Syndrome who Undergo Endoscopic Follow-Up?
Authors
Páramo-Zunzunegui J
Benito-Barbero S
Rubio-López L
Drewniak-Jakubowska J
Publication date
07-10-2022
Publisher
Springer US
Keyword
Colonoscopy
Published in
Journal of Gastrointestinal Cancer / Issue 3/2023
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-022-00872-6

Other articles of this Issue 3/2023

Journal of Gastrointestinal Cancer 3/2023 Go to the issue

Original Research

Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Original Research

Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC

Review Article

Prognostic Role of Preoperative Onodera’s Prognostic Nutritional Index (OPNI) in Gastrointestinal Stromal Tumors: a Systematic Review and Meta-analysis

Case Report

Reversal of Hepatic Dysfunction After Exceptional Responses to Lenvatinib

Original Research

Integrated Analysis Identifies Novel Fusion Transcripts in Laterally Spreading Tumors Suggestive of Distinct Etiology Than Colorectal Cancers

Research

Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits